Company / Free Cash Flow
BIODESIX INC Free Cash Flow History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow
-$23.5M
FY2025
5-year range
-$51.9M / -$23.5M
FY2021-FY2025
Trend
+54.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Free Cash Flow has fluctuated over the past 6 years, ranging from -$52M in FY2024 to -$23M in FY2020.
Based on SEC 10-K filings.
-$24M in FY2025.
Improved from -$46M to -$24M over the past 2 years.
Free Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, free cash flow increased 54.6% year-over-year.
- Peak free cash flow was recorded in FY2020.
- Lowest free cash flow in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score -4.69 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$23.5M | +54.6% |
| FY2024 | -$51.9M | -13.3% |
| FY2023 | -$45.8M | +5.1% |
| FY2022 | -$48.3M | -58.4% |
| FY2021 | -$30.5M | -30.7% |
| FY2020 | -$23.3M | - |
As of FY2025 · SEC Form 10-K · Last checked Jun 21, 2026